Open Government Portal
The purpose of this Notice of Intent to Amend is to notify that, as a result of consultation, Health Canada …
The purpose of this Notice of Amendment is to notify that Health Canada has revised the listing of Vitamin D …
The purpose of this Notice of Amendment is to notify about the additions of:
- Strain Russian BCG-I to the …
The purpose of this Notice of Amendment is to notify about the additions of the following medicinal ingredients on the …
The purpose of this Notice of Amendment is to notify about the additions of: Elexacaftor, Inclisiran, Ospemifene, Pralsetinib and Tafasitamab …
The purpose of this Notice of Amendment is to notify of the addition of the following medicinal ingredients on the …
The purpose of this Notice of Amendment is to notify about the additions of Dequalinium chloride, Enfortumab vedotin, Somatrogon, and …
The purpose of this Notice of Amendment is to notify about the additions of gemtuzumab ozogamacin, gilteritinib, icosapent ethyl, tafamidis, …
The purpose of this Notice of Amendment is to notify about the additions of Alpelisib, Baloxavir marboxil, Betula verrucosa (white …
This guidance document applies to sponsors intending to make changes to new drugs that have received a NOC pursuant to …